Medicare Enrolled
Dr. Chryselle Nazare, MD
Hospitalist Physician · Savannah, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nazare from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nazare?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nazare
Dr. Chryselle Nazare is a hospitalist physician in Savannah, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Nazare performed 4,270 Medicare services across 2,587 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nazare received a total of $4,906 from 38 pharmaceutical and/or device companies across 301 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hospitalist physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nazare is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 1% volume in GA
$4,906 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,270
Medicare services
Top 1% in GA for hospitalist physician
2,587
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~237 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
499 | $75 | $270 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
495 | $8 | $18 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
428 | $13 | $55 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
427 | $8 | $32 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
402 | $10 | $43 |
| Urinalysis, microscopic examination A laboratory test that examines a urine sample under a microscope to check for cells, crystals, bacteria, or other substances. |
395 | $3 | $12 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
334 | $9 | $40 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
179 | $5 | $21 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
178 | $6 | $24 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
178 | $114 | $342 |
| Annual depression screening | 173 | $17 | $54 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
143 | $52 | $183 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
136 | $16 | $69 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
51 | $30 | $76 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
38 | $70 | $163 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
36 | $18 | $75 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
28 | $8 | $35 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
28 | $16 | $49 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
23 | $4 | $18 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $98 | $416 |
| Liver function blood test panel | 20 | $8 | $33 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
19 | $35 | $128 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
13 | $29 | $121 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
13 | $22 | $54 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $11 | $271 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,906
Total received (2018-2024)
Avg $701/year across 7 years
Top 2% in GA for hospitalist physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
301
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,906 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,679
2023
$966
2022
$313
2021
$391
2020
$276
2019
$683
2018
$599
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$249
Lilly USA, LLC
$219
AstraZeneca Pharmaceuticals LP
$205
Astellas Pharma US Inc
$191
GlaxoSmithKline, LLC.
$171
Dexcom, Inc.
$98
PFIZER INC.
$90
Exact Sciences Corporation
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Novartis Pharmaceuticals Corporation
$41
Janssen Pharmaceuticals, Inc
$40
Sumitomo Pharma America, Inc.
$39
Phathom Pharmaceuticals, Inc.
$36
Merck Sharp & Dohme LLC
$32
Amgen Inc.
$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$28
Tris Pharma Inc
$22
Bausch Health US, LLC
$20
Edwards Lifesciences Corporation
$17
IDORSIA PHARMACEUTICALS US INC
$17
Top 3 companies account for 40.1% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$544
Novo Nordisk Inc
$471
Janssen Pharmaceuticals, Inc
$417
Novartis Pharmaceuticals Corporation
$370
Lilly USA, LLC
$354
AstraZeneca Pharmaceuticals LP
$345
Astellas Pharma US Inc
$263
GlaxoSmithKline, LLC.
$258
PFIZER INC.
$246
Allergan Inc.
$179
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$171
Boehringer Ingelheim Pharmaceuticals, Inc.
$159
IDORSIA PHARMACEUTICALS US INC
$141
Dexcom, Inc.
$98
Otsuka America Pharmaceutical, Inc.
$91
Exact Sciences Corporation
$83
ABBVIE INC.
$72
Allergan, Inc.
$68
Sumitomo Pharma America, Inc.
$61
Merck Sharp & Dohme LLC
$47
Amneal Pharmaceuticals LLC
$43
Amgen Inc.
$41
Medtronic, Inc.
$37
Phathom Pharmaceuticals, Inc.
$36
AbbVie Inc.
$35
Harmony Biosciences LLC
$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$28
Corium, LLC
$26
Merck Sharp & Dohme Corporation
$25
Tris Pharma Inc
$22
Axonics, Inc.
$22
Alexion Pharmaceuticals, Inc.
$21
Bausch Health US, LLC
$20
Antares Pharma, Inc.
$19
Edwards Lifesciences Corporation
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$16
Esperion Therapeutics, Inc.
$13
Medtronic USA, Inc.
$12
Top 3 companies account for 29.2% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AREXVY · AVYCAZ · Axonics · Azstarys · BRILINTA · CAPLYTA · CAPVAXIVE · CHANTIX · Cologuard Collection Kit · DALVANCE · DIFICID · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · GARDASIL · GEMTESA · JARDIANCE · KYPHON Balloon Kyphoplasty · LEQVIO · LINQ II · LOKELMA · LifeVest · MOUNJARO · Myrbetriq · NEXLETOL · NOCDURNA · Otezla · Ozempic · PRADAXA · PREVNAR 20 · QULIPTA · QUVIVIQ · Rybelsus · SAMSCA · SHINGRIX · SOLIRIS · SPRAVATO · SYNJARDY · TEFLARO · TRELEGY ELLIPTA · TRULICITY · UBRELVY · UNITHROID · VENASEAL · VOQUEZNA · Veozah · WAKIX · WELLBUTRIN · Wegovy · XARELTO · XIFAXAN · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for hospitalist physician in GA.
Geographic Context
Hospitalist physicians within 10 mi
17
Per 100K population
5.7
County median income
$69,575
Nearest hospital
CANDLER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nazare is a clinical cardiology specialist, with above-average Medicare volume (top 1% in GA), with low-engagement industry engagement in the top 2% of GA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nazare experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Nazare performed 499 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nazare receive payments from pharmaceutical companies?
Yes. Dr. Nazare received a total of $4,906 from 38 companies across 301 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nazare's costs compare to other hospitalist physicians in Savannah?
Dr. Nazare's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nazare) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hospitalist Physicians in Savannah
Browse hospitalist physicians in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Hospitalist Physicians in GA
Hospitalist physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hospitalist Physicians in GA
Which GA hospitalist physicians receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology